Precision BioSciences to Participate in the Truist Securities 2021 Life Sciences Virtual Series
Get Alerts DTIL Hot Sheet
Join SI Premium – FREE
DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced that Derek Jantz, Ph.D., Chief Scientific Officer and Co-Founder will participate in a fireside chat at the Truist Securities 2021 Life Sciences Virtual Series.
Details for the fireside chat are below:
The Truist Securities 2021 Life Sciences Virtual Series
Date: Tuesday, April 13, 2021
Time: 11:00 AM ET
A live webcast of the fireside chat will be accessible on the Company’s website www.precisionbiosciences.com, under the Investors & Media section. An archived replay of the webcasts will be available for approximately 30 days following the presentations.
About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210409005439/en/
Investor Contact:
Alex Kelly
Interim Chief Financial Officer
[email protected]
Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
[email protected]
Source: Precision BioSciences Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inovalis Real Estate Investment Trust Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023
- WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF
- Perk Labs Inc. Announces Extension of Private Placements
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!